|
|
||||||||
Departments of 1 Physiology and 2 Pharmacology and 3 Institute of Cardiovascular Sciences and Medicine, Faculty of Medicine, University of Hong Kong, Hong Kong, China
To test the hypothesis
that heat-shock proteins (HSPs) mediate delayed cardioprotection of
prior
-opioid receptor (
-OR) stimulation, we first correlated
cellular injury and viability with the expression of HSP70s in isolated
rat ventricular myocytes subjected to prior
-OR stimulation with the
selective agonist trans-(±)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide (U-50488H) and delayed lethal simulated ischemia (LSI). Cell
injury and viability were indicated by lactate dehydrogenase release and trypan blue exclusion, respectively. The reduced injury and increased viability after pretreatment with U-50488H were concentration dependent and correlated directly with the expression of both stress-inducible (HSP70) and constitutive (HSC70) proteins. The effects
mimic those with metabolic inhibition preconditioning (MIP). The
cardioprotection against LSI by pretreatment with U-50488H and MIP was
abolished and antagonized, respectively, via blockade of the
-OR by
its selective antagonist, nor-binaltorphimine. We also found
that blockade of the production of HSP70 but not HSC70 blocked the
inhibitory effect of pretreatment with U-50488H on injury and
viability. These observations provide evidence that stress-inducible
HSP70 mediates delayed cardioprotection of prior
-OR stimulation.
-opioid receptor; metabolic inhibition; preconditioning; heat
shock protein 70; cellular injury
This article has been cited by other articles:
![]() |
Q. Wu, Z. Zhao, H. Sun, Y.-l. Hao, C.-d. Yan, and S.-l. Gu Oestrogen changed cardiomyocyte contraction and {beta}-adrenoceptor expression in rat hearts subjected to ischaemia-reperfusion Exp Physiol, September 1, 2008; 93(9): 1034 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, K. W. L. Kam, G. H. Borchert, G. M. Kravtsov, H. J. Ballard, and T. M. Wong Further study on the role of HSP70 on Ca2+ homeostasis in rat ventricular myocytes subjected to simulated ischemia Am J Physiol Cell Physiol, February 1, 2006; 290(2): C583 - C591. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Smith Sonneborn, H. Gottsch, E. Cubin, P. Oeltgen, and P. Thomas Alternative Strategy for Stress Tolerance: Opioids J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2004; 59(5): B433 - B440. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C Chi and J. S Karliner Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors Cardiovasc Res, February 15, 2004; 61(3): 437 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Hampton, A. Shimamoto, C. L. Rothnie, J. Griscavage-Ennis, A. Chong, D. J. Dix, E. D. Verrier, and T. H. Pohlman HSP70.1 and -70.3 are required for late-phase protection induced by ischemic preconditioning of mouse hearts Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H866 - H874. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kato and P. Foex Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists: [La protection myocardique contre les lesions d'ischemie-reperfusion par des anesthesiques : une mise a jour pour les anesthesiologistes] Can J Anesth, October 1, 2002; 49(8): 777 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Patel, A. Hsu, and G. J. Gross Attenuation of heat shock-induced cardioprotection by treatment with the opiate receptor antagonist naloxone Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2011 - H2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Y. Wang, J. J. Zhou, J. Shan, and T.-M. Wong Protein Kinase C-epsilon Is a Trigger of Delayed Cardioprotection against Myocardial Ischemia of kappa -Opioid Receptor Stimulation in Rat Ventricular Myocytes J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 603 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Patel, A. Hsu, and G. J. Gross Attenuation of heat shock-induced cardioprotection by treatment with the opiate receptor antagonist naloxone Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2011 - H2017. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |